FRESENIUS SE+CO.KGAA O.N.
FRESENIUS SE+CO.KGAA O.N./ DE0005785604 /
FRE
|
10/2/2023 5:33:16 PM
|
Chg.
-0.920
|
Volume |
Bid5:35:37 PM |
Ask5:35:37 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
28.480EUR
|
-3.13%
|
99,547
Turnover: 2.85 mill. |
28.290Bid Size: 650 |
28.530Ask Size: 650 |
16.09 bill.EUR |
3.22% |
11.70 |
Business description
Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
Management board & Supervisory board
| CEO |
| Michael Sen |
| Management board |
| Sara Hennicken, Dr. Ernst Wastler, Dr. Francesco De Meo, Sebastian Biedenkopf, Pierluigi Antonelli , Helen Giza |
| Supervisory board |
| Wolfgang Kirsch, Prof. Dr. D. Michael Albrecht, Stefanie Balling , Bernd Behlert , Michael Diekmann , Grit Genster , Konrad Kölbl , Frauke Lehmann , Prof. Dr. med. Iris Löw-Friedrich , Oscar Romero de Paco , Susanne Zeidler , Dr. Christoph Zindel |
Company data
| Name: |
Fresenius SE & Co. KGaA |
| Address: |
Else-Kröner-Straße 1,D-61352 Bad Homburg |
| Phone: |
+49-6172-608-0 |
| Fax: |
- |
| E-mail: |
pr-fre@fresenius.com
|
| Internet: |
www.fresenius.de |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
56.49% |
| IPO date: |
12/18/1986 |
Investor relations
| Name: |
Markus Georgi |
| IR phone: |
+49-6172-608-2485 |
| IR Fax: |
+49-6172-608-2488 |
| IR e-mail: |
ir-fre@fresenius.com
|
Company calendar
|
CW 44 | 11/2/2023
Interim Report 3rd Quarter/9 Months
|